EVALUATION OF THE CHROMATOGRAPHIC PROCEDURE FOR THE PREPARATION OF A HIGH-PURITY C1-ESTERASE INHIBITOR CONCENTRATE FROM CRYOSUPERNATANT PLASMA

被引:1
|
作者
TEH, LC
FROGER, M
机构
[1] Department of Blood Products Development, Auckland Regional Blood Centre, Auckland Hospital, Private Bag
来源
关键词
D O I
10.1016/0378-4347(92)80303-8
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This report is an analysis of the parameters involved in the preparation of a C1-esterase inhibitor concentrate. We investigated ways to improve the purification by finding the optimal pH, ionic strength, and quantity of chromatographic media to use at each step. The optimisation of the process gave a greater than two-fold increase in both yield and purity over published methods. The product retained more than 50% activity upon dry heat-treatment at 80-degrees-C for 72 h, and the yield of the heat-treated product was 180 I.U./kg of plasma.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 50 条
  • [21] Inhibition of systemic inflammation by plasma protein C1-esterase inhibitor in a human inflammation model
    Visser, Tjaakje
    Dorresteijn, Mirrin
    Koenderman, Anky
    Leenen, Luke
    Pickkers, Peter
    Koenderman, Leo
    INFLAMMATION RESEARCH, 2010, 59 : S133 - S134
  • [22] Acquired Angioedema Requiring Reduced C1-Esterase Inhibitor Concentrate Treatment When Combined with Warfarin and Danazol
    Whitelaw, J.
    Denegri, J.
    Growe, G. H.
    Bigham, M.
    TRANSFUSION, 2011, 51 : 192A - 192A
  • [23] Berinert® (C1-Esterase Inhibitor Concentrate) Treatment Is Not Related to Prothrombotic Risk Based On Preclinical Efficacy and Safety Investigations
    Herzog, Eva
    Schuermann, Daniel
    Raquet, Elmar
    Zollner, Sabine
    Pragst, Ingo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB109 - AB109
  • [24] Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase Inhibitor on Coagulation and Fibrinolytic Parameters
    Reshef, Avner
    Levy, Donald
    Longhurst, Hilary
    Cicardi, Marco
    Craig, Timothy
    Keith, Paul K.
    Feussner, Annette
    Feuersenger, Henrike
    Machnig, Thomas
    Prusty, Subhransu
    Pragst, Ingo
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (05) : 690 - 693
  • [25] C1 ESTERASE-INHIBITOR CONCENTRATE PREVENTS HYPOTENSION FROM PLASMA-PROTEIN SOLUTIONS
    VANDERSTARRE, P
    SINCLAIR, D
    DAMEN, J
    BRUMMELHUIS, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (22): : 1276 - 1276
  • [26] C-1 INHIBITOR STRUCTURE-ACTIVITY-RELATIONSHIPS - DIFFERENT STRUCTURAL REQUIREMENTS FOR INHIBITION OF PLASMA KALLIKREIN AND C1-ESTERASE
    PATSTON, P
    SCHIFFERLI, JA
    COURTNEY, M
    SCHAPIRA, M
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 66 - 66
  • [27] Preparation of high-purity strontium carbonate from celestite concentrate by double decomposition-roasting process
    Liu, Mudan
    Jiang, Tao
    Li, Guanghui
    TMS 2008 ANNUAL MEETING SUPPLEMENTAL PROCEEDINGS, VOL 3: GENERAL PAPER SELECTIONS, 2008, : 149 - 161
  • [28] PREPARATION OF HIGH-PURITY GD-153 .1. EXTRACTION-CHROMATOGRAPHIC PURIFICATION FROM ELEMENTAL IMPURITIES
    MELNIK, MI
    KUZNETSOV, RA
    FILIMONOV, VT
    SOVIET RADIOCHEMISTRY, 1992, 34 (06): : 697 - 701
  • [29] C1-Esterase Inhibitor Concentrate for Acute Laryngeal Hereditary Angioedema (HAE) Attacks: Different Treatment Response Based on Dosing Regimen?
    Bork, Konrad
    Bernstein, Jonathan A.
    Machnig, Thomas
    Craig, Timothy J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB250 - AB250
  • [30] Lack of evidence for increased thrombotic risk with high doses of C1-esterase inhibitor concentrate in a non-clinical model of venous stasis and arterial thrombosis
    Herzog, E.
    Schuermann, D.
    Raquet, E.
    Zollner, S.
    Dickneite, G.
    Pragst, I
    ALLERGY, 2013, 68 : 435 - 435